BMI LabBioelectronic Materials & Interfaces

New paper: how endothelial cells respond to drug-doped polypyrrole coatings

Salicylate- and dexamethasone-doped polypyrrole on biodegradable iron, tested against human endothelial cells — and what that means for designing safe stent coatings.

Endothelial Cytotoxicity of Drug-Doped Polypyrrole Coatings on Biodegradable Iron for Stent Applications has been published in Advanced Materials Interfaces.

The study looks at how electrochemically deposited polypyrrole, doped with either salicylate or dexamethasone, interacts with human endothelial cells (HUVECs) when used to coat biodegradable iron-based stents. A coating that releases a drug is only useful if the vessel wall tolerates it, so the results read as design guidelines for the next generation of biodegradable vascular implants rather than as a single measurement.

With Jagoda Litowczenko-Cybulska (Center for Advanced Technologies, Adam Mickiewicz University in Poznań) and Piotr Jasiński. Funded by the National Science Centre (NCN).

See the publication list for the full reference.

Originally posted on LinkedIn ↗

← All news